Recent advances in the prevention of congenital heart disease

Current Opinion in Pediatrics

Volumn 18, Issue 5, 2006, Pages 484-489

  Huhta, James C ^a   Linask, Kersti ^a   Bailey, Lynn ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; METHIONINE; PYRIDOXINE;

CARBON METABOLISM; CARDIOVASCULAR RISK; CONGENITAL HEART DISEASE; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; DNA METHYLATION; DNA POLYMORPHISM; EDITORIAL; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEALTH CARE POLICY; HOMOZYGOSITY; HUMAN; HUNGARY; MEDICAL RESEARCH; NEURAL TUBE DEFECT; NONHUMAN; NUTRITION; PREGNANCY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RECURRENCE RISK; RISK REDUCTION; SPINA BIFIDA; UNITED STATES; VITAMIN SUPPLEMENTATION;

ANIMALS; DISEASE MODELS, ANIMAL; FOLIC ACID; FORECASTING; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; POLYMORPHISM, GENETIC; RISK FACTORS; VITAMIN B COMPLEX;

EID: 33748754936     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000245347.45336.d7     Document Type: Editorial

References (45)

1. Bailey LB, Rampersaud GC, Kauwell GPA. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J Nutr 2003; 133:1961S-1968S.
2. Laurence KM, James N, Miller MH, et al. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 1981; 282:1509-1511.
3. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991; 338:131-137.
4. Czeizel A, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832-1835.
5. Doe J. Folate prevents NTD. N Engl J Med 1999; 341:1485-1490.
6. Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am Heart J 2004; 147:425-439.
7. Boneva RS, Botto LD, Morre CA, et al. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001; 103:2376-2381.
8. Griffin KJ, Elkin TD, Smith CJ. Academic outcomes in children with congenital heart disease. Clin Pediatr (Phila) 2003; 42:401-409.
9. Sanchez-Cascos A. The recurrence risk in congenital heart disease. Eur J Cardiol 1978; 7 (2-3):197-210.
10. Whittemore R. Maternal transmission of congenital heart disease. Am J Cardiol 1988; 61:499-500.
11. Hoffman JI. Congenital heart disease: incidence and inheritance. Pediatr Clin North Am 1990; 37:25-43.
12. Caputo S, Russo MG, Capozzi G, et al. Congenital heart disease in a population of dizygotic twins: an echocardiographic study. Int J Cardiol 2005; 102:293-296.
13. Goldmuntz E. The epidemiology and genetics of congenital heart disease. Clin Perinatol 2001; 28:1-10.
14. Gelb BD. Genetic basis of congenital heart disease. Curr Opin Cardiol 2004; 19:110-115.
15. Gill HK, Splitt M, Sharland GK, et al. Patterns of recurrence of congenital heart disease: an analysis of 6 640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol 2003; 42:923-929.
16. Shelnutt KP, Kauwell GP, Gregory JF, et al. Methylenetetrahydrofolate reductase 677C→T polymorphism affects DNA methylation in response to controlled folate intake in young women. J Nutr Biochem 2004; 15:1554-1560.
17. Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part III: Folic acid: pharmacology, therapeutic recommendations, and economics. Ann Pharmacother 1998; 32:1087-1095.
18. Forrester MB. Folic acid calls to poison centers in Texas, 1998-2003. Hum Exp Toxicol 2005; 24:423-427.
19. Piedrahita JA, Oetama B, Bennett GD, et al. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 1999; 23:228-232.
20. Burgoon JM, Selhub J, Nadeau M, et al. Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model. Teratology 2002; 65:219-227.
21. Barbera JP, Rodriguez TA, Greene ND, et al. Folic acid prevents exencephaly in Cited2 deficient mice. Hum Mol Genet 2002; 11:283-293.
22. Conway SJ, Henderson DJ, Kirby ML, et al. Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse. Cardiovasc Res 1997; 36:163-173.
23. Conway SJ, Godt RE, Hatcher CJ, et al. Neural crest is involved in development of abnormal myocardial function. J Mol Cell Cardiol 1997; 29:2675-2685.
24. Li D, Rozen R. Maternal folate deficiency affects proliferation, but not apoptosis in embryonic mouse heart. J Nutr 2006; 136:1774-1778.
25. Zhao R, Russell RG, Wang Y, et al. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem 2001; 276:10224-10228.
26. Spiegelstein O, Mitchell LE, Merriweather MY, et al. Embryonic development of folate binding protein-1 (Folbp1) knockout mice: effects of the chemical form, dose, and timing of maternal folate supplementation. Dev Dyn 2004; 231:221-231.
27. Czeizel AE. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 1998; 78:151-161.
28. Shaw GM, O'Malley CD, Wasserman CR, et al. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995; 59:536-545.
29. Scanlon KS, Ferencz C, Loffredo CA, et al. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltimore-Washington Infant Study Group. Epidemiology 1998; 9:95-98.
30. Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol 2000; 151:878-884.
31. Shaw GM, Iovannisci DM, Yang W, et al. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A 2005; 138A:21-26.
32. Rozen R. Polymorphisms of folate and cobalamin metabolism. Cambridge, UK: Cambridge Press; 2001.
33. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A 2002; 99:5606-5611.
34. Junker R, Kotthoff S, Vielhaber H, et al. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 2001; 51:251-254.
35. Wenstrom KD, Johanning GL, Johnston KE, et al. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 2001; 184:806-812; discussion 812-817.
36. Hobbs CA, Cleves MA, Melnyk S, et al. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 2005; 81:147-153.
37. Hobbs CA, Malik S, Zhao W, et al. Maternal homocysteine and congenital heart defects. J Am Coll Cardiol 2006; 47:683-685.
38. Kapusta L, Haagmans ML, Steegers EA, et al. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 1999; 135:773-774.
39. van Beynum IM, Kapusta L, den Heijer M, et al. Maternal MTHFR 677C→T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006; 27:981-987.
40. Hernandez-Diaz MM, Walker AM, Mitchell AA. Folic acid antagonist during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608-1614.
41. Shaw GM, Zhu H, Lammer EJ, et al. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol 2003; 158:747-752.
42. Li Y. Study of serum Hcy and polymorphisms of Hcy metabolic enzymes in 192 families affected by congenital heart disease. Beijing Da Xue Xue Bao 2005; 37:75-80.
43. Cheng J, Zhu WL, Dao JJ, et al. Relationship between polymorphism of methylenetetrahydrofolate dehydrogenase and congenital heart defect. Biomed Environ Sci 2005; 18:58-64.
44. Kim KN, Kim KY, Chang N. Effects of the interaction between the C677T 5,10-methylenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women. N Eur J Clin Nutr 2004; 58:10-16.
45. 12 insufficiency and the risk of fetal neural tube defects. Q Med J 2003; 96:289-295.